Genetics of bipolar disorder: an overview

Author/s
Stefano Porcelli, Raffaele Salfi, Alessandro Serretti
Citation
Issue 3 Summer 2013
CEPiP.2013;1:104-115
Abstract

Bipolar disorder (BPD) is a mood disorder caused by the interaction among a large number of genes and the environment. Recently, with the improvement of genome analysis techniques and the introduction of Genome Wide Association Studies (GWAS), the investigation of the genetic causes of BPD has moved several steps forward, allowing the confirmation of previous results and the identification of new genes involved in the pathogenesis of the disorder. Furthermore, in the last few years, several studies focused on the investigation of rare genetic variants, copy number variants (CNV) and epigenetic modifications, leading to a more complete knowledge of the picture. The aim of the present review is to give to the reader a comprehensive view of the current knowledge about the genetics of BPD, focusing on the most investigated genes and their biological function in the context of the more accepted theories about the pathogenesis of the disorder.

Most confirmed liability genes are involved in the serotoninergic, glutamatergic, GABAergic and circadian systems. In particular, a large amount of evidence was found for glutamatergic NMDA and Kainate receptors and some genes of the glutamate cycle, which are thought to be involved in a possible neurotoxic effect on neurotransmission. Other relevant genes are CLOCK, ARNTL and PER3 which may increase the risk of disease by altering circadian rhythms, through the modulation of the serotonin system.

In conclusion, it is still not possible to determine the exact genetic basis of BPD, because several genes are likely to be involved in the pathogenesis of the disorder, as well as environmental factors. Nonetheless, thanks to recent technological advantages, several steps forward have been made, allowing the identification of the main systems involved in the genesis of BPD. Through further technological improvement and the use of specific endophenotypes, more related to genetic and epigenetic variants compared to BPD itself, in the next few years the identification of the exact genetic basis of BPD might be an achievable aim for psychiatric research.

Keywords: bipolar disorder, genetics, epigenetics, endophenotypes

Cite as: Cutting Edge Psychiatry in Practice 2013, 3(1):104-115; https://doi.org/10.65031/vdgv8304

References

  1. Kessler RC, Merikangas KR, Wang PS. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annual review of clinical psychology. 2007;3:137-58. Epub 2007/08/25. https://doi.org/10.1146/annurev.clinpsy.3.022806.091444
  2. Ferrari AJ, Baxter AJ, Whiteford HA. A systematic review of the global distribution and availability of prevalence data for bipolar disorder. Journal of affective disorders. 2011;134 (1-3):1-13. Epub 2010/12/07. https://doi.org/10.1016/j.jad.2010.11.007
  3. American Psychiatric Association., American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders : DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000. xxxvii, 943 p. p. https://doi.org/10.1176/appi.books.9780890423349
  4. Sajatovic M. Bipolar disorder: disease burden. The American journal of managed care. 2005;11 (3 Suppl):S80-4. Epub 2005/08/16.     
  5. McCombs JS, Ahn J, Tencer T, Shi L. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. Journal of affective disorders. 2007;97 (1-3):171-9. Epub 2006/07/25. https://doi.org/10.1016/j.jad.2006.06.018
  6. Craddock N, Jones I. Genetics of bipolar disorder. Journal of medical genetics. 1999;36 (8):585-94. Epub 1999/08/28.         
  7. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373 (9659):234-9. Epub 2009/01/20. https://doi.org/10.1016/s0140-6736(09)60072-6
  8. Bender RE, Alloy LB. Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories. Clinical psychology review. 2011;31 (3):383-98. Epub 2011/02/22. https://doi.org/10.1016/j.cpr.2011.01.004
  9. Mandelli L, Serretti A, Marino E, Pirovano A, Calati R, Colombo C. Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. Int J Neuropsychopharmacol. 2007;10 (4):437-47. Epub 2006/06/08. https://doi.org/10.1017/s1461145706006882
  10. Serretti A, Mandelli L. The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions. Molecular psychiatry. 2008;13 (8):742-71. Epub 2008/03/12. https://doi.org/10.1038/mp.2008.29
  11. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993. xii, 248 p. p. 
  12. Manji HK, Lenox RH. The nature of bipolar disorder. The Journal of clinical psychiatry. 2000;61 Supp  13:42-57. Epub 2001/01/12.       
  13. Carlson PJ, Singh JB, Zarate CA, Jr., Drevets WC, Manji HK. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. 2006;3 (1):22-41. Epub 2006/02/24. https://doi.org/10.1016/j.nurx.2005.12.009
  14. Strakowski SM, Delbello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular psychiatry. 2005;10 (1):105-16. Epub 2004/09/02. https://doi.org/10.1038/sj.mp.4001585
  15. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS spectrums. 2005;10 (10):808-19. Epub 2006/01/10. https://doi.org/10.1017/s1092852900010403
  16. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. The American journal of psychiatry. 2008;165 (7):820-9. Epub 2008/06/04. https://doi.org/10.1176/appi.ajp.2008.08010098
  17. Porcelli S, Fabbri C, Serretti A. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2012;22 (4):239-58. Epub 2011/12/06. https://doi.org/10.1016/j.euroneuro.2011.10.003
  18. Seifuddin F, Mahon PB, Judy J, Pirooznia M, Jancic D, Taylor J, et al. Meta-analysis of genetic association studies on bipolar disorder. American journal of medical genetics Part B Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2012. Epub 2012/05/11. https://doi.org/10.1002/ajmg.b.32057
  19. Carrard A, Salzmann A, Malafosse A, Karege F. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. Journal of affective disorders. 2011;132 (3):450-3. Epub 2011/04/02. https://doi.org/10.1016/j.jad.2011.03.018
  20. Yosifova A, Mushiroda T, Stoianov D, Vazharova R, Dimova I, Karachanak S, et al. Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. Journal of affective disorders. 2009;117 (1-2):87-97. Epub 2009/03/31. https://doi.org/10.1016/j.jad.2008.12.021
  21. Abdolmaleky HM, Yaqubi S, Papageorgis P, Lambert AW, Ozturk S, Sivaraman V, et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophrenia research. 2011;129 (2-3):183-90. Epub 2011/05/10. https://doi.org/10.1016/j.schres.2011.04.007
  22. Charych EI, Liu F, Moss SJ, Brandon NJ. GABA (A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders. Neuropharmacology. 2009;57 (5-6):481-95. Epub 2009/07/28. https://doi.org/10.1016/j.neuropharm.2009.07.027
  23. Zhao C, Xu Z, Wang F, Chen J, Ng SK, Wong PW, et al. Alternative-splicing in the exon-10 region of GABA (A) receptor beta (2) subunit gene: relationships between novel isoforms and psychotic disorders. PloS one. 2009;4 (9):e6977. Epub 2009/09/19. https://doi.org/10.1371/journal.pone.0006977
  24. Sheng G, Demers M, Subburaju S, Benes FM. Differences in the Circuitry-Based Association of Copy Numbers and Gene Expression Between the Hippocampi of Patients With Schizophrenia and the Hippocampi of Patients With Bipolar Disorder. Archives of general psychiatry. 2012. Epub 2012/02/09. https://doi.org/10.1001/archgenpsychiatry.2011.1882
  25. Ginsberg SD, Hemby SE, Smiley JF. Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder. Pharmacology, biochemistry, and behavior. 2012;100 (4):705-11. Epub 2011/10/19. https://doi.org/10.1016/j.pbb.2011.09.015
  26. Blumberg HP, Kaufman J, Martin A, Whiteman R, Zhang JH, Gore JC, et al. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Archives of general psychiatry. 2003;60 (12):1201-8. Epub 2003/12/10. https://doi.org/10.1001/archpsyc.60.12.1201
  27. Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Molecular psychiatry. 2010;15 (4):384-92. Epub 2009/06/03. https://doi.org/10.1038/mp.2009.47
  28. Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophrenia bulletin. 2007;33 (4):905-11. Epub 2007/06/07. https://doi.org/10.1093/schbul/sbm053
  29. Pickard BS, Knight HM, Hamilton RS, Soares DC, Walker R, Boyd JK, et al. A common variant in the 3’UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder. Proceedings of the National Academy of Sciences of the United States of America. 2008;105 (39):14940-5. Epub 2008/10/01. https://doi.org/10.1073/pnas.0800643105
  30. Gratacos M, Costas J, de Cid R, Bayes M, Gonzalez JR, Baca-Garcia E, et al. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2009;150B (6):808-16. Epub 2008/12/17. https://doi.org/10.1002/ajmg.b.30902
  31. Zarate C, Jr., Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G. Glutamatergic modulators: the future of treating mood disorders? Harvard review of psychiatry. 2010;18 (5):293- 303. Epub 2010/09/10. https://doi.org/10.3109/10673229.2010.511059
  32. Saus E, Brunet A, Armengol L, Alonso P, Crespo JM, Fernandez-Aranda F, et al. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. Journal of psychiatric research. 2010;44 (14):971-8. Epub 2010/04/20. https://doi.org/10.1016/j.jpsychires.2010.03.007
  33. Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. Journal of affective disorders. 2012;136 (1-2):63-71. Epub 2011/09/20. https://doi.org/10.1016/j.jad.2011.08.017
  34. Uezato A, Meador-Woodruff JH, McCullumsmith RE. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Bipolar disorders. 2009;11 (7):711-25. Epub 2009/10/21. https://doi.org/10.1111/j.1399-5618.2009.00752.x
  35. Zhan L, Kerr JR, Lafuente MJ, Maclean A, Chibalina MV, Liu B, et al. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathology and applied neurobiology. 2011;37 (2):206-19. Epub 2010/09/30. https://doi.org/10.1111/j.1365-2990.2010.01128.x
  36. Dallaspezia S, Benedetti F. Melatonin, circadian rhythms, and the clock genes in bipolar disorder. Current psychiatry reports. 2009;11 (6):488-93. Epub 2009/11/17. https://doi.org/10.1007/s11920-009-0074-1
  37. Etain B, Milhiet V, Bellivier F, Leboyer M. Genetics of circadian rhythms and mood spectrum disorders. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2011;21 Suppl 4:S676-82. Epub 2011/08/13. https://doi.org/10.1016/j.euroneuro.2011.07.007
  38. Partonen T. Clock gene variants in mood and anxiety disorders. J Neural Transm. 2012. Epub 2012/04/28. https://doi.org/10.1007/s00702-012-0810-2
  39. Serretti A, Drago A. Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms. Neuropsychobiology. 2010;62 (1):61-71. Epub 2010/05/11. https://doi.org/10.1159/000314311
  40. WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447 (7145):661-78. Epub 2007/06/08.     
  41. Ferreira MA, O’Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature genetics. 2008;40 (9):1056-8. Epub 2008/08/20. https://doi.org/10.3410/f.1123953.580041
  42. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Molecular psychiatry. 2008. https://doi.org/10.1038/sj.mp.4002012
  43. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N, et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature genetics. 2011;43 (10):977-83. Epub 2011/09/20. https://doi.org/10.1038/nm.2524
  44. Tabares-Seisdedos R, Rubenstein JL. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Molecular psychiatry. 2009;14 (6):563-89. Epub 2009/02/11. https://doi.org/10.1038/mp.2009.2
  45. Moreau MP, Bruse SE, David-Rus R, Buyske S, Brzustowicz LM. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biological psychiatry. 2011;69 (2):188-93. Epub 2010/12/25. https://doi.org/10.1016/j.biopsych.2010.09.039
  46. Ciarleglio CM, Resuehr HE, McMahon DG. Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues. Neuroscience. 2011;197:8-16. Epub 2011/10/04. https://doi.org/10.1016/j.neuroscience.2011.09.036
  47. Ciranna L. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Current neuropharmacology. 2006;4 (2):101-14. Epub 2008/07/11. https://doi.org/10.2174/157015906776359540
  48. Cannon TD, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annual review of clinical psychology. 2006;2:267-90. Epub 2007/08/25.